Rebuttal Letter to the Editor Kloosterboer et al., Ther Drug Monit 2018;40: 344-350.

Kloosterboer, Sanne M; de Winter, Brenda C M; Bahmany, Soma; Al-Hassany, Linda; Dekker, Annet; Dieleman, Gwen C; van Gelder, Teun; Dierckx, Bram; Koch, Birgit C P

Kloosterboer, Sanne M; de Winter, Brenda C M; Bahmany, Soma; Al-Hassany, Linda; Dekker, Annet; Dieleman, Gwen C; van Gelder, Teun; Dierckx, Bram; Koch, Birgit C P.

Afiliación

Kloosterboer SM; Departments of Hospital Pharmacy and.
de Winter BCM; Child and Adolescent Psychiatry/Psychology, Erasmus MC, Rotterdam, the Netherlands.
Bahmany S; Departments of Hospital Pharmacy and.
Al-Hassany L; Departments of Hospital Pharmacy and.
Dekker A; Departments of Hospital Pharmacy and.
Dieleman GC; Middin, The Hague, the Netherlands.
van Gelder T; Child and Adolescent Psychiatry/Psychology, Erasmus MC, Rotterdam, the Netherlands.
Dierckx B; Departments of Hospital Pharmacy and.
Koch BCP; Child and Adolescent Psychiatry/Psychology, Erasmus MC, Rotterdam, the Netherlands.

Ther Drug Monit ; 40(6): 762, 2018 12.

Article en En | MEDLINE | ID: mdl-30444494

Asunto(s)

Antipsicóticos; Monitoreo de Drogas; Pruebas con Sangre Seca; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antipsicóticos / Monitoreo de Drogas Límite: Humans Idioma: En Revista: Ther Drug Monit Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google